The Economic Burden of Anxiety Disorders in the 1990s
The DOI matches its Crossref record.
Abstract
BACKGROUND: We assess the annual economic burden of anxiety disorders in the United States from a societal perspective. METHOD: Using data from the National Comorbidity Study, we applied multivariate regression techniques to calculate the costs associated with anxiety disorders, after adjusting for demographic characteristics and the presence of comorbid psychiatric conditions. Based on additional data, in part from a large managed care organization, we estimated a human capital model of the societal cost of anxiety disorders. RESULTS: We estimated the annual cost of anxiety disorders to be approximately $42.3 billion in 1990 in the United States, or $1542 per sufferer. This comprises $23.0 billion (or 54% of the total cost) in nonpsychiatric medical treatment costs, S13.3 billion (31%) in psychiatric treatment costs, $4.1 billion (10%) in indirect workplace costs, $1.2 billion (3%) in mortality costs, and $0.8 billion (2%) in prescription pharmaceutical costs. Of the $256 in workplace costs per anxious worker, 88% is attributable to lost productivity while at work as opposed to absenteeism. Posttraumatic stress disorder and panic disorder are the anxiety disorders found to have the highest rates of service use. Other than simple phobia, all anxiety disorders analyzed are associated with impairment in workplace performance. CONCLUSION: Anxiety disorders impose a substantial cost on society, much of which may be avoidable with more widespread awareness, recognition, and appropriate early intervention.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Economic costs associated with anxiety disorders are among the highest of all mental disorders studied.[2][3][4][5][6]”
From The Classification of Anxiety and Fear-Related Disorders in the ICD-11: Review: Anxiety and Fear-Related Disorders in ICD-11 (2016) · cites this paper as [3]
Citations
Cited by
Items 601–700 of 1,001
Bouchard, S., Dugas, M. J., Belleville, G., Langlois, F., Gosselin, P., Robillard, G., Corno, G., & Marchand, A. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11195924 · Cited by 21
“Individuals with GAD report high levels of psychological distress, low quality of life and high impairment at work, with high rates of absenteeism and low productivity [6].”
Chen, C. V., Brummet, J. L., Jordan, C. L., & Breedlove, S. M. (2015) · Endocrinology · doi:10.1210/en.2015-1417 · Cited by 23
“770 Chen et al Partial CNS AR Elimination and Anxiety Endocrinology, February 2016, 157(2):764–773”
BackgroundMethodInfluentialWhy do people with an anxiety disorder utilize more nonmental health care than those without?
Levy, A. G., Maselko, J., Bauer, M., Richman, L. S., & Kubzansky, L. D. (2007) · Health Psychology · doi:10.1037/0278-6133.26.5.545 · Cited by 23
Gada, E., Khan, D. A., DeFina, L. F., & Brown, E. S. (2013) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2013.08.027 · Cited by 23
Grieb, Z. A., & Ragan, C. M. (2019) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2019.07.239 · Cited by 24
Mortari, M. R., do Couto, L. L., dos Anjos, L. C., Araujo, M. D. A., Mourão, C., Schwartz, C. A., & Ferreira, L. A. F. (2012) · Pharmacognosy Magazine · doi:10.4103/0973-1296.103657 · Cited by 20
“Anxiety disorders are also enormously costly in terms of individual suffering and direct medical and indirect social cost.[17,18] Moreover, when first-line treatments are not effective, treatment-resistant anxiety disorders may be another serious problem.”
BackgroundCo-occurrence of Insomnia and Anxiety Disorders: A Review of the Literature
Marcks, B. A., & Weisberg, R. B. (2009) · American Journal of Lifestyle Medicine · doi:10.1177/1559827609334681 · Cited by 24
“Estimates of the cost associated with anxiety disorders in 1998 were over $63 billion, with more than half of the costs associated with anxiety disorders being due to overutilization of primary care services.(47) Furthermore, the cost of anxiety disorders accounts for 31% of total mental health care costs in the Unite…”
BackgroundSocial Anxiety in Children and Adolescents
Detweiler, M. F., Comer, J. S., & Albano, A. M. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-375096-9.00009-2 · Cited by 32
Pilot Study of INSIGHT Therapy in African American Women
Mynatt, S., Wicks, M. N., & Bolden, L. V. (2008) · Archives of Psychiatric Nursing · doi:10.1016/j.apnu.2007.10.007 · Cited by 23
“This cost estimate includes the indirect costs associated with the reduced productivity and the loss of quality of life that often occur in persons with the disorder (Creed et al., 2002; Greenberg et al., 1999).”
BackgroundSheehan, D. V., Meyers, A. L., Prakash, A., Robinson, M. J., Swindle, R. W., Russell, J. M., & Mallinckrodt, C. H. (2008) · Current Medical Research and Opinion · doi:10.1185/03007990802293643 · Cited by 24
Mental Health and Mental Illness In The Workplace: Diagnostic and Treatment Issues
Bender, A., & Kennedy, S. H. (2004) · A Nudge Too Far? A Nudge at All? On Paying People to Be Healthy · doi:10.12927/hcpap..16824 · Cited by 24
“Anxiety disorders are also highly prevalent and, with the exception of simple phobia, are associated with impairment in workplace performance (Greenberg et al. 1999).”
BackgroundA New Treatment Algorithm for Posttraumatic Stress Disorder
Davidson, J. R. T., Bernik, M., Connor, K. M., Friedman, M. J., Jobson, K. O., Kim, Y., Lecrubier, Y., Ma, H., Njenga, F. G., Stein, D. J., et al. (2005) · Psychiatric Annals · doi:10.3928/00485713-20051101-04 · Cited by 22
Self-citationAnxiety Disorders in Children and Adolescents
Castellanos, D., & Hunter, T. (2010) · PsycEXTRA Dataset · doi:10.1037/e556312011-001 · Cited by 21
Johnson, M. R., Gold, P. B., Siemion, L., Magruder, K. M., Frueh, B. C., & Santos, A. B. (2000) · The International Journal of Psychiatry in Medicine · doi:10.2190/txnb-v7vu-7h32-c7yt · Cited by 20
Harvison, K. W., Woodruff-Borden, J., & Jeffery, S. E. (2004) · Journal of Clinical Psychology in Medical Settings · doi:10.1023/b:jocs.0000037616.60987.89 · Cited by 20
“%) of this is due to nonpsychiatric medical treatment costs (Greenberg et al., 1999).”
BackgroundFomenko, A., Dümmler, D., Aktürk, Z., Eck, S., Teusen, C., Karapetyan, S., Dawson, S., Löwe, B., Hapfelmeier, A., Linde, K., et al. (2025) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd015456 · Cited by 46
Wootton, B. M., Bragdon, L. B., Steinman, S. A., & Tolin, D. F. (2015) · Journal of Anxiety Disorders · doi:10.1016/j.janxdis.2015.01.007 · Cited by 20
Grover, K. W., Goodwin, R. D., & Zvolensky, M. J. (2012) · Addictive Behaviors · doi:10.1016/j.addbeh.2012.01.014 · Cited by 21
The FRIENDS Emotional Health Program for Minority Groups at Risk
Iizuka, C. A., Barrett, P. M., Gillies, R. M., Cook, C. R., & Miller, D. (2014) · Journal of School Health · doi:10.1111/josh.12127 · Cited by 24
Chen, M., Pritchard, C. E., Fortune, D., Kodi, P., & Grados, M. A. (2019) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2019.1668270 · Cited by 20
“3 billion dollars per year in the US [6].”
BackgroundComer, J. S., Gallo, K. P., Korathu-Larson, P. A., Pincus, D. B., & Brown, T. A. (2012) · Depression and Anxiety · doi:10.1002/da.21981 · Cited by 21
Eight years later: outcomes of CBT‐treated versus untreated anxious children
Adler Nevo, G. W., Avery, D., Fiksenbaum, L., Kiss, A., Mendlowitz, S., Monga, S., & Manassis, K. (2014) · Brain and Behavior · doi:10.1002/brb3.274 · Cited by 20
“They generate significant distress in the individual and an economic burden to society (Greenberg et al. 1999).”
BackgroundPössel, P., Schneider, S., & Seemann, S. (2006) · Verhaltenstherapie · doi:10.1159/000094918 · Cited by 21
Breathing Retraining in the Treatment of Panic Disorder: Efficacy, Caveats and Indications
Taylor, S. J. (2001) · Scandinavian Journal of Behaviour Therapy · doi:10.1080/02845710118895 · Cited by 31
“The economic costs of panic disorder – such as direct healthcare costs, lost productivity and social welfare expenditures – exceed the costs associated with many other anxiety disorders, such as social phobia, generalized anxiety disorder and obsessive-compulsive disorder (Greenberg et al., 1999; Kennedy & Schwab, 199…”
BackgroundStein, D. J. (2006) · Annals of Clinical Psychiatry · doi:10.1080/10401230600801192 · Cited by 25
Neurosurgery for mental disorder
Christmas, D. M. B., Matthews, K., & Eljamel, S. (2004) · The British Journal of Psychiatry · doi:10.1192/bjp.185.2.173-a · Cited by 21
Paulus, D. J., Hayes-Skelton, S. A., & Norton, P. J. (2015) · Group Dynamics: Theory, Research, and Practice · doi:10.1037/gdn0000023 · Cited by 19
“3 Billion annually in the United States (Greenberg et al., 1999) making them the most costly class of psychological disorders (Rice & Miller, 1998).”
BackgroundWhat Works in Foster Care? Key Components of Success From the Northwest Foster Care Alumni Study
Pecora, P. J., Kessler, R. C., Williams, J. R., Downs, A. C., English, D. J., White, J., & O’Brien, K. (2009) · doi:10.1093/acprof:oso/9780195175912.001.0001 · Cited by 48
Self-citationAnxiety sensitivity and attentional bias to threat interact to prospectively predict anxiety
Bardeen, J. R., & Daniel, T. A. (2018) · Cognitive Behaviour Therapy · doi:10.1080/16506073.2018.1466911 · Cited by 24
The buffering effect of attentional control on the relationship between cognitive fusion and anxiety
Thomas, K. N., & Bardeen, J. R. (2020) · Behaviour Research and Therapy · doi:10.1016/j.brat.2020.103653 · Cited by 19
A computational network perspective on pediatric anxiety symptoms
Abend, R., Bajaj, M. A., Coppersmith, D. D. L., Kircanski, K., Haller, S. P., Cardinale, E. M., Salum, G. A., Wiers, R. W. H. J., Salemink, E., Pettit, J. W., et al. (2020) · Psychological Medicine · doi:10.1017/s0033291720000501 · Cited by 23
“Pediatric anxiety is prevalent, impairing, and associated with adverse outcomes (Beesdo, Knappe, & Pine, 2009; Greenberg et al., 1999; Kessler & Wang, 2008; Stein, Scott, de Jonge, & Kessler, 2017).”
Anxiety, Health Risk Factors, and Chronic Disease
Sawchuk, C. N., & Olatunji, B. O. (2011) · American Journal of Lifestyle Medicine · doi:10.1177/1559827610393868 · Cited by 21
Mohammadi, A., Birashk, B., & Gharaie, B. (2013) · PubMed Central · Cited by 24
Muschalla, B. (2017) · European Journal of Work and Organizational Psychology · doi:10.1080/1359432x.2017.1384378 · Cited by 23
“Long-term sick leave and a prolonged return to work after an illness are relevant problems for the professional history of the affected person and also for the companies and society (Greenberg et al., 1999; Haschke, Hutter, & Baumeister, 2012; Seyedmehdi et al., 2013).”
BackgroundScreening for anxiety in primary care: why bother?
Lang, A. J., & Stein, M. B. (2002) · General Hospital Psychiatry · doi:10.1016/s0163-8343(02)00216-5 · Cited by 20
Fanselow, M. S., & Sterlace, S. R. (2014) · Wiley eBooks · doi:10.1002/9781118468135.ch6 · Cited by 36
“costs such as long-term unemployment and co-morbidity with other health problems are taken into account (Greenberg et al., 1999).”
Rad, M. S., Moohebati, M., & Mohajeri, S. A. (2022) · Inflammopharmacology · doi:10.1007/s10787-022-01083-y · Cited by 22
“Anxiety and depression are crucial public health issues, affecting the rising in hospitalizations and death (Greenberg et al. 1999).”
BackgroundRytwinski, N. K., Avena, J. S., Echiverri-Cohen, A. M., Zoellner, L. A., & Feeny, N. C. (2013) · Journal of Health Psychology · doi:10.1177/1359105312474913 · Cited by 20
“These physical complaints result in both undue suffering and significant medical costs (e.g. Greenberg et al., 1999; Walker et al., 2003).”
BackgroundLinden, M., Zubrägel, D., & Bär, T. (2011) · Clinical Psychology & Psychotherapy · doi:10.1002/cpp.712 · Cited by 24
Cognitive Risk Factors to the Development of Anxiety and Depressive Disorders in Adolescents
Dia, D. A., & Bradshaw, W. J. (2008) · Child and Adolescent Social Work Journal · doi:10.1007/s10560-008-0156-7 · Cited by 24
Zatzick, D., Russo, J. E., Rivara, F. P., Roy‐Byrne, P., Jurkovich, G. J., & Katon, W. J. (2005) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2004.09.003 · Cited by 20
Gao, D., Xiang, Q., Lu, G., Tong, J., Jiang, W., Yu, X., Wang, R., Lv, Z., & Li, D. (2022) · BMC Psychology · doi:10.1186/s40359-022-00934-1 · Cited by 17
“The GAD-7 scale is an effective tool to identify possible causes of generalized anxiety disorder [30], which had good reliability and validity in previous studies [31, 32].”
MethodUtilization of Mental Health Services after Disasters
Elhai, J. D., & Ford, J. D. (2009) · Cambridge University Press eBooks · doi:10.1017/cbo9780511730030.022 · Cited by 17
Tang, A. C., Reeb‐Sutherland, B. C., Romeo, R. D., & McEwen, B. S. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.03.021 · Cited by 20
Ballanger, B., Bath, K. G., & Mandairon, N. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.06.007 · Cited by 24
Budylin, T., Guariglia, S. R., Duran, L. I., Behring, B. M., Shaikh, Z., Neuwirth, L. S., & Banerjee, P. (2019) · Behavioural Brain Research · doi:10.1016/j.bbr.2019.112062 · Cited by 20
Scheuer, H., Engstrom, A., Thomas, P., Moodliar, R., Moloney, K., Walen, M. L., Johnson, P., Seo, S., Vaziri, N., Martinez, A., et al. (2020) · Contemporary Clinical Trials · doi:10.1016/j.cct.2020.105970 · Cited by 18
Norton, P. J., Provencher, M. D., Kilby, C. J., & Roberge, P. (2021) · Depression and Anxiety · doi:10.1002/da.23184 · Cited by 23
Venlafaxine in the treatment of panic disorder
Katzman, M. A., & Jacobs, L. (2007) · Neuropsychiatric Disease and Treatment · doi:10.2147/nedt.2007.3.1.59 · Cited by 18
“The annual cost of anxiety disorders in the United States was estimated to be US $42.3 billion in 1990, and US $65 billion in 1994 (Greenberg et al 1999; Dupont et al 2002).”
BackgroundInfluentialFarrell, L. J., Sijbenga, A., & Barrett, P. M. (2009) · Advances in School Mental Health Promotion · doi:10.1080/1754730x.2009.9715694 · Cited by 25
Zlotnick, C., Bruce, S. E., Weisberg, R. B., Shea, M. T., Machan, J. T., & Keller, M. B. (2003) · Comprehensive Psychiatry · doi:10.1016/s0010-440x(03)00005-1 · Cited by 18
Posttraumatic stress disorder in callers to the Anxiety Disorders Association of America
Zhang, W., Ross, J., & Davidson, J. R. T. (2004) · Depression and Anxiety · doi:10.1002/da.10138 · Cited by 17
Self-citationJ⊘rgensen, T. R., Stein, D. J., Despiégel, N., Drost, P., Hemels, M. E. H., & Baldwin, D. S. (2006) · Annals of Pharmacotherapy · doi:10.1345/aph.1h156 · Cited by 21
Bosmans, J. E., Schreuders, B., van Marwijk, H. W., Smit, J. H., van Oppen, P., & van Tulder, M. W. (2012) · BMC Family Practice · doi:10.1186/1471-2296-13-98 · Cited by 16
“Moreover, mental health problems are associated with high health care costs and lost productivity costs, thus causing a huge economic burden as well [4-6].”
BackgroundCost-effectiveness of Brief Behavioral Therapy for Pediatric Anxiety and Depression in Primary Care
Lynch, F. L., Dickerson, J. F., Rozenman, M. S., González, A., Schwartz, K. T. G., Porta, G., O'Keeffe-Rosetti, M. C., Brent, D. A., & Weersing, V. R. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.1778 · Cited by 35
Pupo, M. C., Serafim, P. M., & Mello, M. F. (2015) · Psychiatry Research · doi:10.1016/j.psychres.2015.05.030 · Cited by 18
“The estimated costs associated with PTSD are higher than any other anxiety disorder (Greenberg et al., 1999) and also has one of the highest rates of service use, adding substantial economic and humanistic impact on patients and health care systems.”
BackgroundZarrabian, S., Farahizadeh, M., Nasehi, M., & Zarrindast, M. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881115622239 · Cited by 19
“Anxiety, stress, and trauma-related disorders are large-scale health concerns in many countries (Greenberg et al., 1999).”
BackgroundPieters, E., Raedt, R. D., Enock, P. M., Putter, L. M. S. D., Braham, H., McNally, R. J., & Koster, E. H. W. (2016) · Cognitive Therapy and Research · doi:10.1007/s10608-016-9803-z · Cited by 19
“However, many people suffering from these disorders do not seek or receive adequate treatment because efficacious treatments are inaccessible, expensive, time-consuming, or perceived as stigmatizing (Greenberg et al. 1999; Kessler and Wang 2008; Kessler et al. 2008; McNally and McNally 2016).”
BackgroundSampaio, F. M. C., Araújo, O., Sequeira, C., Lluch‐Canut, T., & Martins, T. V. (2017) · International Journal of Nursing Knowledge · doi:10.1111/2047-3095.12169 · Cited by 20
“…in the United States, affecting 18.1% of adults yearly (Kessler, Chiu, Demler, & Walters, 2005) and, in 1990, accounted for an annual expenditure of $42.3 billion in medical and psychiatric costs, as well as medication costs, high mortality rates and productivity loss (Greenberg et al., 1999).”
InfluentialKristman, V. L., Lowey, J., Fraser, L., Armstrong, S. J., & Sawula, S. (2019) · BMC Public Health · doi:10.1186/s12889-019-6976-x · Cited by 19
“5 billion in 2010 in the US, with 45–47% attributable to direct costs, 5% to suicide-related costs, and 48–50% to workplace costs [3], those being primarily (88%) lost productivity [4].”
BackgroundGenetics of anxiety disorders: Complexities and opportunities
Smoller, J. W., & Faraone, S. V. (2008) · American Journal of Medical Genetics Part C Seminars in Medical Genetics · doi:10.1002/ajmg.c.30167 · Cited by 20
“The direct and indirect costs of these illnesses exceed $40 billion annually [Greenberg et al., 1999].”
BackgroundInvolvement of dorsal hippocampal NMDA-glutamatergic system in anxiety-related behaviors of rats
Solati, J., & Salari, A. (2011) · Neurochemical Journal · doi:10.1134/s1819712411030081 · Cited by 16
Unresolved Questions About Treatment-Resistant Anxiety Disorders
Stein, D. J., & Seedat, S. (2004) · CNS Spectrums · doi:10.1017/s1092852900022355 · Cited by 15
Feasibility study of mindfulness-based cognitive therapy for anxiety disorders in a Japanese setting
Sado, M., Park, S., Ninomiya, A., Sato, Y., Fujisawa, D., Shirahase, J., & Mimura, M. (2018) · BMC Research Notes · doi:10.1186/s13104-018-3744-4 · Cited by 18
Primary Prevention for Mental Health: Results of an Exploratory Cognitive-Behavioral College Course
Schiraldi, G. R., & Brown, S. L. (2001) · The Journal of Primary Prevention · doi:10.1023/a:1011040231249 · Cited by 16
“In 1990, 54% of the annual costs of anxiety disorders were attributed to nonpsychiatric medical costs (Greenberg et al., 1999).”
BackgroundExercise for the Management of Anxiety and Stress-Related Disorders
Herring, M. P. (2018) · Exercise-Based Interventions for Mental Illness · doi:10.1016/b978-0-12-812605-9.00002-2 · Cited by 15
Aday, J. S., & Carlson, J. M. (2017) · Medical Hypotheses · doi:10.1016/j.mehy.2017.09.002 · Cited by 18
Stone, D. I. G., Elkins, R. M., Gardner, M. M., Boger, K. D., & Sperling, J. (2023) · Child Psychiatry & Human Development · doi:10.1007/s10578-023-01500-5 · Cited by 18
“[15, 16, 22–26] Beyond the individual, the economic costs of youth anxiety disorders and OCD to families and society are substantial [27, 28].”
Reinecke, A., & Harmer, C. J. (2016) · Psychopathology Review · doi:10.5127/pr.035113 · Cited by 18
“…an enormous impact on individual life quality and psychosocial functioning, including impairments in relationships, parenting and career productivity (P. E. Greenberg et al., 1999; Leon, Portera, & Weissman, 1995; Mendlowicz & Stein, 2000; Pollack & Marzol, 2000; Zaider, Heimberg, & Iida, 2010).”
BackgroundDuloxetine in the treatment of generalized anxiety disorder
Berg, C. V., & Wright (2009) · International Journal of General Medicine · doi:10.2147/ijgm.s4492 · Cited by 17
“In fact, some estimates put the US economic cost of anxiety disorders, inclusive of GAD, at US$42 to US$63 billion per year.(5,6) A recent retrospective review of healthcare claims in patients In te rn at io na l J ou rn al o f G en er al M ed ic in e do w nl oa de d fr om h ttp s: //w w w .”
Duloxetine for the treatment of generalized anxiety disorder: a review
Khan, A., & Macaluso, M. (2008) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s3486 · Cited by 19
“Approximately 16 million people in the United States suffer from anxiety disorders alone, while another 12 million experience both anxiety and at least one other psychiatric disorder.(1)”
BackgroundLau, J. Y. F., & Pile, V. (2014) · Clinical Psychological Science · doi:10.1177/2167702614549596 · Cited by 21
Macdonald, A., Greene, C. J., Torres, J. G., Frueh, B. C., & Morland, L. A. (2012) · Psychological Trauma Theory Research Practice and Policy · doi:10.1037/a0027313 · Cited by 15
Effects of ascorbic acid on anxiety state and affect in a non-clinical sample
Moritz, B., Schwarzbold, M. L., Guarnieri, R., Díaz, A. P., Rodrigues, A. L. S., & Dafré, A. L. (2017) · Acta Neurobiologiae Experimentalis · doi:10.21307/ane-2017-068 · Cited by 17
“However, persistent or exaggerat‑ ed anxiety is pathological and constitutes the hallmark of anxiety disorders, which are the most common psy‑ chiatric disorders, with a lifetime prevalence of almost 30% (Greenberg et al. 1999, Kessler et al. 2005, Viana and Andrade 2012).”
BackgroundUsing Integrative Yoga Therapeutics in the Treatment of Comorbid Anxiety and Depression
Forbes, B., Akturk, C., Cummer-Nacco, C., Gaither, P., Gotz, J., Harper, A., & Hartsell, K. (2008) · International Journal of Yoga Therapy · doi:10.17761/ijyt.18.1.p8171x45n6328107 · Cited by 18
New Trends in the Treatment of Anxiety Disorders
Brawman‐Mintzer, O., & Yonkers, K. A. (2004) · CNS Spectrums · doi:10.1017/s1092852900002339 · Cited by 19
Wan, G., Crown, W., Berndt, E. R., Finkelstein, S. N., & Ling, D. C. (2002) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2002.tb11293.x · Cited by 15
Self-citationAnxiety Disorders: A Developmental Vulnerability-Stress Perspective
Williams, N. L., Reardon, J. M., Murray, K. T., & Cole, T. M. (2005) · Sage eBooks · doi:10.4135/9781452231655.n11 · Cited by 20
Eradicating war memories: Neuroscientific reality and ethical concerns
Kroes, M. C. W., & Liivoja, R. (2018) · International Review of the Red Cross · doi:10.1017/s1816383118000437 · Cited by 17
Somatization, Depression, and Anxiety Disorders in a Rhinology Practice
Alam, E. S., Musselman, D. L., Chyou, D. E., Shukri, G., Levine, C. G., Sanghvi, S., Zhang, H., & Casiano, R. R. (2019) · American Journal of Rhinology and Allergy · doi:10.1177/1945892419841317 · Cited by 14
Boyd, J. E., O’Connor, C., Protopopescu, A., Jetly, R., Rhind, S. G., Lanius, R. A., & McKinnon, M. C. (2019) · Chronic Stress · doi:10.1177/2470547019841599 · Cited by 19
“PTSD is associated with significant functional impairment, including reductions in work- and mental health-related quality of life,(3) impaired workplace performance,(4) and high use of medical care services.(5) Importantly, impairments in quality of life may persist following remission of PTSD symptoms.”
BackgroundThe Value of Physical Symptoms in Screening For Posttraumatic Stress Disorder in the Military
Graham, K., Searle, A., Hooff, M. V., Lawrence‐Wood, E., & McFARLANE, A. C. (2019) · Assessment · doi:10.1177/1073191119864662 · Cited by 14
“Considering that those with untreated PTSD more frequently utilize health care and generate substantial direct and indirect costs (Greenberg et al., 1999), false negatives may be more costly than the additional follow-up incurred by false positives.”
BackgroundHealthcare costs and quality of life associated with the long-term outcome of anxiety disorders
Higgins, C., Chambers, J. A., Major, K., & Durham, R. C. (2020) · Anxiety Stress & Coping · doi:10.1080/10615806.2020.1839731 · Cited by 18
Anxiety Symptom Severity and Functional Recovery Or Relapse
Stein, D. J., Bandelow, B., Dolberg, O. T., Andersen, H. F., & Baldwin, D. S. (2009) · Annals of Clinical Psychiatry · doi:10.1177/104012370902100204 · Cited by 14
Chapter 5.1 Phenomenology of anxiety disorders
Nutt, D. J., de Miguel, B. G., & Davies, S. (2008) · Handbook of behavioral neuroscience · doi:10.1016/s1569-7339(07)00017-3 · Cited by 22
Priebe, K., Roth, M., Krüger, A., Glöckner-Fink, K., Dyer, A., Steil, R., Salize, H. J., Kleindienst, N., & Bohus, M. (2016) · Psychiatrische Praxis · doi:10.1055/s-0042-106068 · Cited by 19
“In US-amerikanischen Studien fand sich bei PTBS im Vergleich zu Angststörungen eine größere Inanspruchnahme stationärer und ambulanter Behandlung [3, 4].”
BackgroundMuschalla, B. (2016) · Springer eBooks · doi:10.1007/978-3-319-32331-2_5 · Cited by 14
Anxiety and Related Disorders: An Introduction
Cox, R. C., & Olatunji, B. O. (2018) · Cambridge University Press eBooks · doi:10.1017/9781108140416.001 · Cited by 16
Startle during threat longitudinally predicts functional impairment independent of DSM diagnoses
Stevens, E. S., Lieberman, L., Funkhouser, C. J., Correa, K. A., & Shankman, S. A. (2019) · Psychiatry Research · doi:10.1016/j.psychres.2019.02.072 · Cited by 16
“Northwestern University, Department of Psychiatry, Chicago, Illinois, 60611 United States, stew.shankman@northwestern.edu (S. Shankman).”
BackgroundInfluentialVirtual Reality Exposure Therapy for Posttraumatic Stress Disorder
Sherrill, A. M., Rothbaum, A. O., McSweeney, L. B., & ROTHBAUM, B. O. (2019) · Psychiatric Annals · doi:10.3928/00485713-20190716-02 · Cited by 14
The Cost Effectiveness of Pharmacological Treatments for Generalized Anxiety Disorder
Mavranezouli, I., Meader, N., Cape, J. D., & Kendall, T. (2013) · PharmacoEconomics · doi:10.1007/s40273-013-0031-z · Cited by 23
“3 billion or US$1542 per patient in 1990 [9].”
BackgroundGuest, J. F., Russ, J., & Lenox‐Smith, A. (2005) · The European Journal of Health Economics · doi:10.1007/s10198-004-0272-z · Cited by 17
Elhai, J. D., Kashdan, T. B., Snyder, J. J., North, T. C., Heaney, C. J., & Frueh, B. C. (2006) · Depression and Anxiety · doi:10.1002/da.20188 · Cited by 13
“For example, nationally representative community studies demonstrate that trauma history increases the likelihood of mental health (MH) and medical treatment use [Rosenheck and Massari, 1993; Sorenson and Siegel, 1992], and PTSD increases the intensity of MH service use [Greenberg et al., 1999].”
BackgroundNeurosurgery for mental disorder
Christmas, D. M. B., Morrison, C., Eljamel, S., & Matthews, K. (2004) · Advances in Psychiatric Treatment · doi:10.1192/apt.10.3.189 · Cited by 15
Skaer, T. L., Robison, L. M., Sclar, D. A., & Galin, R. S. (2000) · Clinical Drug Investigation · doi:10.2165/00044011-200020040-00007 · Cited by 17
Interpersonal Processes in the Anxiety Disorders
Alden, L. E., & Regambal, M. J. (2010) · Wiley eBooks · doi:10.1002/9781118001868.ch26 · Cited by 18
Korte, K. J., & Schmidt, N. B. (2020) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2020.04.001 · Cited by 19
“These disorders result in considerable distress, impairment in daily functioning and an economic burden of billions of dollars in any given year (Greenberg et al., 1999).”
BackgroundLandová, E., Rádlová, S., Pidnebesna, A., Tomeček, D., Janovcová, M., Peléšková, Š., Sedláčková, K., Štolhoferová, I., Polák, J., Hlinka, J., et al. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1196785 · Cited by 18
“The scheme represents each step during the test (completing each step was honored by one point, 7 points total): moving closer to the terrarium (points 1 to 3), removing the cloth and looking at the spider (4), opening the terrarium (5), touching the spider with a pencil (6) and ultimately touching it with a finger (7…”
BackgroundAntidepressants as first-line agents in the current pharmacotherapy of anxiety disorders.
Rivas-Vazquez, R. A. (2001) · Professional Psychology Research and Practice · doi:10.1037/0735-7028.32.1.101 · Cited by 18
“Greenberg et al. (1999) estimated the 1990 annual cost of anxiety disorders in the United States to be approximately $42.”
BackgroundKaldewaij, R., Reinecke, A., & Harmer, C. J. (2019) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2019.07.002 · Cited by 14
Metadata
- Authors
- Greenberg, P. E., Sisitsky, T., Kessler, R. C., Finkelstein, S. N., Berndt, E. R., Davidson, J. R. T., Ballenger, J. C., & Fyer, A. J.
- Affiliations
- Analysis Group (United States) (US)
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 1999-07-15
- Volume
- 60
- Issue
- 7
- Pages
- 427-435
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W2020344785
- Cited by
- 1,242
- References
- 0
- Citations by year
- 2026: 11 · 2025: 11 · 2024: 18 · 2023: 19 · 2022: 25 · 2021: 38 · 2020: 39 · 2019: 47 · 2018: 52 · 2017: 48 · 2016: 73 · 2015: 74 · 2014: 72 · 2013: 82 · 2012: 81
- FWCI
- 46.95
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Keywords
- anxiety disorders, economic burden, social costs, health care costs, workplace productivity loss, absenteeism, mortality costs, post-traumatic stress disorder, panic disorder, specific phobia, comorbidities, human capital model
- MeSH terms
- Adolescent, Adult, Anxiety Disorders, Mental Disorders, Cost Allocation, Direct Service Costs, Educational Status, Employment, Family Characteristics, Female, Humans, Male, Managed Care Programs, Middle Aged, Risk Factors, United States, Comorbidity, Drug Costs, Health Care Costs, Workplace, Cost of Illness, Marital Status, Models, Economic, Racial Groups
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.